Media Centre

Featured Media Release

07 May 2014 - GSK encourages research excellence as award nominations open

GSK has opened nominations for what is regarded as one of the most prestigious research awards available to the Australian science community - the 2014 GSK Award for Research Excellence


Media Releases

Avandia (rosiglitazone maleate) - Australian Update

Following a review of Avandia® (rosiglitazone maleate) by the European Medicines Agency (EMA) and the US Food and Drug Administration], each agency has today informed GlaxoSmithKline (GSK) of their individual regulatory decisions and resulting...



Avandia (rosiglitazone maleate): GSK Australia spokesperson available post FDA Advisory Group Recommendation.

GlaxoSmithKline (GSK) Australia Medical Director, Dr Camilla Chong will be available to speak with Australian journalists about the outcome of the U.S. Food and Drug Administration (FDA) Advisory Committee recommendation in relation to the...



ViiV Healthcare Lauched in Australia

New specialist HIV company dedicated to delivering advances in HIV treatment and care



GlaxoSmithKline Completes Acquisition of Stiefel

GlaxoSmithKline plc (GSK) announced that it has completed its acquisition of Stiefel


< 3 4 5 6 7 8 9 10 11 12 13